Nanospere, Inc.
Country not established
- Devices
- 1
What Nanospere, Inc. makes
Nanospere, Inc. manufactures the Verigene Enteric Pathogen Nucleic Acid Test (EP), a diagnostic device designed to detect nucleic acids from enteric pathogens in clinical samples.
The Verigene Enteric Pathogen Nucleic Acid Test (EP) is classified as a Class II device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Verigene Enteric Pathogen Nucleic Acid Test (Ep) Ref K142033
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nanospere, Inc. have in the registry?
The registry currently lists 1 device for Nanospere, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nanospere, Inc.'s devices?
Among its 1 most recently registered device, Nanospere, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Nanospere, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Nanospere, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nanospere, Inc. in the registry?
The most recently registered devices listed for Nanospere, Inc. include VERIGENE ENTERIC PATHOGEN NUCLEIC ACID TEST (EP).